🔎 Trials Near Me

Gara Jalqabaatti › Myelodysplastic Syndromes › Connecticut › New Haven

Qorannoo klinikaalii Myelodysplastic Syndromes New Haven, CT keessatti

Qorannoo 8 Myelodysplastic Syndromes f New Haven fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Miili 3 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06484062

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Yale, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07422480

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Namoota walitti qabaa jiraSadarkaa 3
  • Smilow Cancer Hospital at Yale-New Haven, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT06499285

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Yale University, Yale Cancer Center, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06656494

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • GSK Investigational Site, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT06847867

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Yale University, New Haven
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317

Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti

Qorannoo biroo New Haven keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.